Market News AIOpen the app

PolyPid will share new research on its D-PLEX100 product at the IDWeek 2026 conference.

TrialRead the original at globenewswire.com
Neutral

PolyPid will present an exploratory analysis of data from its phase studies. The source reports no findings, so it does not change the outlook for D-PLEX100.

PYPD · PolyPid Ltd.

AI read · Neutral

The AI's read

The presentation shows PolyPid is continuing to study D-PLEX100. The source gives no findings from the analysis, so it does not show whether the product's chances of preventing infections have changed.

Get alerts for PYPD

Follow PolyPid Ltd. (PYPD) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for PYPD
Free on the App Store and Google Play, or on the web.